Intracoronary reopro during percutaneous coronary intervention in acute and stable patient can influence stent thrombosis formation (IRPASST) study

Background: In patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty, abciximab reduces major adverse cardiac events (MACE). Most clinical trials have studied mainly intravenous administration. Intracoronary (IC) bolus application of abciximab causes very high...

Descripció completa

Dades bibliogràfiques

Autors principals:	Mohammed Balghith, Ali Al-Ghamdi, El harif Zain, Ahmed Al-Saileek
Format:	Artigo
Idioma:	Inglês
Publicat:	Wolters Kluwer Medknow Publications 2013-01-01
Col·lecció:	Heart Views
Matèries:	Abciximab acute coronary artery disease intracoronary intravenous stent thrombosis tirofiban
Accés en línia:	http://www.heartviews.org/article.asp?issn=1995-705X;year=2013;volume=14;issue=2;spage=62;epage=67;aulast=Balghith
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!